Connect with us

Business

F.D.A. Grants Emergency Authorization of Antibody Treatment Given to Trump – The New York Times

The treatment, made by the biotech company Regeneron, is a cocktail of two powerful antibodies that have shown promise for people who get it early in the course…

Published

on

post featured image
ADVERTISEMENT

Regeneron has suggested that the people who benefit the most from the treatment are those who have not yet mounted an antibody response and who also have high viral loads but learning who those people are would require separate tests that are not routinely given to patients who test positive for the virus. Company executives have acknowledged that at first, such tests may not be available, and the emergency authorization notes that people at high risk include those who are over 65, or have underlying…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

post featured image
Forget Black Friday Deals, These Dividend Stocks Are on Sale – Motley Fool
post featured image
European stocks pause and U.S. futures rise despite lockdown extensions and AstraZeneca vaccine concerns – MarketWatch
post featured image
How to get a Black Friday travel deal during the pandemic – Fox News